Last reviewed · How we verify
Platelet Aggregation Inhibition
Approved treatments
- Persantin · Boehringer Ingelheim
- Persantine · Boehringer Ingelheim
Persantine works by inhibiting platelet activation and aggregation by blocking the equilibrative nucleoside transporter 1.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Platelet Aggregation Inhibition patent landscape — cliff calendar, originator estates, attackable patents
- Platelet Aggregation Inhibition treatment landscape brief
- Platelet Aggregation Inhibition treatment updates RSS
Frequently asked questions about Platelet Aggregation Inhibition
What drugs treat Platelet Aggregation Inhibition?
Tracked treatments include Persantin, Persantine.
What is the treatment for Platelet Aggregation Inhibition?
Standard treatment for Platelet Aggregation Inhibition includes Persantin, Persantine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Platelet Aggregation Inhibition patent cliff · Platelet Aggregation Inhibition CI report
- Treatment: Persantin · Boehringer Ingelheim
- Treatment: Persantine · Boehringer Ingelheim
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing